FindTrial
Sign In

Genoss Daegu-Kyungpook registry

A multi-center prospective cohortof patients with coronary artery disease treated with GenossTM, Sirolimus-eluting: Genoss Daegu-Kyungpook registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005519
Enrollment
500
Registered
2020-10-21
Start date
2020-10-29
Completion date
Unknown
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Keimyung University Dongsan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Adults over 19 years old -Patients who received Genoss™ stent for coronary artery disease -Those who have agreed in writing to participate in this registry study

Exclusion criteria

Exclusion criteria: -Those who do not agree to participate in the research by the research subject or the research subject representative -Patients with different types of stents inserted together, except when Genoss™ treatment failed during the PCI procedure

Design outcomes

Primary

MeasureTime frame
Failure to treat target lesions (Psychogenic death, non-fatal myocardial infarction, multiple indicators of target lesion reoperation)—

Secondary

MeasureTime frame
Failure to treat target lesions;Failure to treat target vessels;all-cause death;cardiac death;Total death and myocardial infarction;Psychogenic death and myocardial infarction;repeat revascularization;target vessel revascularization;target lesion revascularization;stent thrombosis;procedural success;Antiplatelet drug use by follow-up period—

Countries

Korea, Republic of

Contacts

Public ContactChang-wook Nam

Keimyung University Dongsan Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026